«If you put humans as the target, even though you are not going to make a human baby, it will be provocative, it will be misinterpreted, but people will engage,» says Andrew Hessel, a self - described futurist and biotechnology catalyst at Autodesk in San Francisco, California, a successful software company that specializes in 3D design programs for architecture and other fields that has been exploring
synthetic biology applications in recent years.
IDT's primary business is the production of custom, synthetic nucleic acids for
molecular biology applications, including qPCR, next generation sequencing, synthetic biology, and functional genomics.
«The long - term goal is to understand the stability and targeting mechanisms important to synthetic
biology applications involving, for example, chemical sensing between living cells and electronic detectors as well as the development of biofuel cells.»
The geneXplain platform is an online toolbox and workflow management system for a broad range of bioinformatic and
systems biology applications that we have used for the modeling of colorectal cancer in SYSCOL.
Competition: Most of the venture capital for
synthetic biology applications has gone to companies like Seattle - based Juno Therapeutics, which does genetic engineering to help patients fight disease.
«It was a natural collaboration to put these two pieces of technology together because individually, they're both great, but together they enable extremely powerful
molecular biology applications,» said Wallace.
Beyond the numerous synthetic
biology applications, Efcavitch envisions that cheaper and more rapid DNA synthesis will push innovation in nanotechnology applications, such as using DNA for biosensors and data storage.
This discovery provides proof - of - concept for the use of natural GroEL / ES to fold D - proteins for a variety of mirror - image drug discovery and synthetic
biology applications.
Cellular memory is crucial to many natural biological processes and sophisticated synthetic
biology applications.
This workshop is part of a larger Woodrow Wilson Center / MIT (SynBERC) endeavor to prototype risk assessment methods for their utility in identifying early ‐ stage hazards and research directions for synthetic
biology applications.
To achieve this, we work between biophysics, materials science and synthetic biology to gain new insights into the physical phenomena which drive out of equilibrium processes in cells and to reimagine and translate these insights into novel, robust and dynamic systems for synthetic
biology applications.
As synthetic biology moves forward, it is critical to understand how the USPTO and EPO will react and respond to synthetic
biology applications.